Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation

American Journal of Pathology

Volumn 174, Issue 3, 2009, Pages 869-880

  Fouassier, Laura ^a,b,g   Rosenberg, Peter ^c   Mergey, Martine ^a,b   Saubaméa, Bruno ^d   Clapéron, Audrey ^a,b   Kinnman, Nils ^e   Chignard, Nicolas ^a,b   Jacobsson Ekman, Gunilla ^c   Strandvik, Birgitta ^f   Rey, Colette ^a,b   Barbu, Véronique ^a,b   Hultcrantz, Rolf ^c   Housset, Chantal ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Serono International SA   (Switzerland)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; EZRIN; MOESIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN EBP50; RADIXIN; SMALL INTERFERING RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; BILE DUCT DISEASE; BILE DUCT LIGATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOPLASM; EPITHELIUM CELL; FEMALE; GENE CONTROL; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER DISEASE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 62549110794     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080079     Document Type: Article

References (49)

1. Weinman EJ, Steplock D, Shenolikar S: cAMP-mediated inhibition of the renal brush border membrane Na+-H+ exchanger requires a dissociable phosphoprotein cofactor. J Clin Invest 1993, 92:1781-1786
2. Morales FC, Takahashi Y, Kreimann EL, Georgescu MM: Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Proc Natl Acad Sci USA 2004, 101:17705-17710
3. Yun CH, Oh S, Zizak M, Steplock D, Tsao S, Tse CM, Weinman EJ, Donowitz M: cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci USA 1997, 94:3010-3015
4. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS: Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 1999, 140:2976-2982
5. Fouassier L, Duan CY, Feranchak AP, Yun CH, Sutherland E, Simon F, Fitz JG, Doctor RB: Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 2001, 33:166-176
6. Voltz JW, Weinman EJ, Shenolikar S: Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 2001, 20:6309-6314
7. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE, Cohen WA, Ramesh V, Louis DN: NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 2001, 158:57-62
8. Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S: EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003, 38:178-186
9. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A, Reshkin SJ: The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 2007, 18:1768-1780
10. Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z: Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin- binding phosphoprotein 50 in breast cancer. Histopathology 2007, 51:40-53
11. Maudsley S, Zamah AM, Rahman N, Blitzer JT, Luttrell LM, Lefkowitz RJ, Hall RA: Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol Cell Biol 2000, 20:8352-8363
12. He J, Lau AG, Yaffe MB, Hall RA: Phosphorylation and cell cycledependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. J Biol Chem 2001, 276:41559-41565
13. Lazar CS, Cresson CM, Lauffenburger DA, Gill GN: The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol Biol Cell 2004, 15:5470-5480
14. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM: PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 2006, 25:910-920
15. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ, McCrea PD, Georgescu MM: Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 2007, 26:5290-5299
16. Pan Y, Wang L, Dai JL: Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1). Breast Cancer Res 2006, 8:R63
17. Ediger TR, Park SE, Katzenellenbogen BS: Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements. Mol Endocrinol 2002, 16:1828-1839
18. Alvaro D, Alpini G, Onori P, Perego L, Svegliata Baroni G, Franchitto A, Baiocchi L, Glaser SS, Le Sage G, Folli F, Gaudio E: Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 2000, 119:1681-1691
19. Alvaro D, Alpini G, Onori P, Franchitto A, Glaser S, Le Sage G, Gigliozzi A, Vetuschi A, Morini S, Attili AF, Gaudio E: Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 2002, 123:336-344
20. Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E: Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol 2006, 169:877-888
21. Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, Lienhart A, Housset C: Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 2007, 87:292-303
22. Tuchweber B, Desmoulière A, Brochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G: Proliferation and phenotypic modulation of portal fibroblasts in early stages of cholestatic fibrosis in the rat. Lab Invest 1996, 74:265-278
23. Marucci L, Baroni GS, Mancini R, Benedetti A, Jezequel AM, Orlandi F: Cell proliferation following extrahepatic biliary obstruction. Evaluation by immunohistochemical methods. J Hepatol 1993, 17:163-169
24. Chignard N, Mergey M, Barbu V, Finzi L, Tiret E, Paul A, Housset C: VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium. Hepatology 2005, 42:549-557
25. Kinnman N, Hultcrantz R, Barbu V, Rey C, Wendum D, Poupon R, Housset C: PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest 2000, 80:697-707
26. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, Prellwitz M, Meyer zum Buschenfelde K: Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1985, 1:579-596
27. Wang W, Soroka CJ, Mennone A, Rahner C, Harry K, Pypaert M, Boyer JL: Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes. Gastroenterology 2006, 131:878-884
28. Kikuchi S, Hata M, Fukumoto K, Yamane Y, Matsui T, Tamura A, Yonemura S, Yamagishi H, Keppler D, Tsukita S: Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Genet 2002, 31:320-325
29. Hegedüs T, Sessler T, Scott R, Thelin W, Bakos E, Varadi A, Szabo K, Homolya L, Milgram SL, Sarkadi B: C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. Biochem Biophys Res Commun 2003, 302:454-461
30. Corpechot C, Ping C, Wendum D, Matsuda F, Barbu V, Poupon R: Identification of a novel 974C->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. Am J Gastroenterol 2006, 101:2427-2432
31. Kipp H, Pichetshote N, Arias IM: Transporters on demand: intrahepatic pools of canalicular ATP binding cassette transporters in rat liver. J Biol Chem 2001, 276:7218-7224
32. Misra S, Varticovski L, Arias IM: Mechanisms by which cAMP increases bile acid secretion in rat liver and canalicular membrane vesicles. Am J Physiol 2003, 285:G316-G324
33. Wang B, Yang Y, Friedman PA: Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway. Mol Biol Cell 2008, 19:1637-1645
34. Georgescu MM: NHERF1: molecular brake on the PI3K pathway in breast cancer. Breast Cancer Res 2008, 10:106
35. Slott PA, Liu MH, Tavoloni N: Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990, 99:466-477
36. Polimeno L, Azzarone A, Zeng QH, Panella C, Subbotin V, Carr B, Bouzahzah B, Francavilla A, Starzl TE: Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology 1995, 21:1070-1078
37. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, Brunt EM, Crawford JM, Crosby HA, Desmet V, Finegold MJ, Geller SA, Gouw AS, Hytiroglou P, Knisely AS, Kojiro M, Lefkowitch JH, Nakanuma Y, Olynyk JK, Park YN, Portmann B, Saxena R, Scheuer PJ, Strain AJ, Thung SN, Wanless IR, West AB: Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004, 39:1739-1745
38. Zhou H, Rogler LE, Teperman L, Morgan G, Rogler CE: Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology 2007, 45:716-724
39. Guerra L, Fanelli T, Favia M, Riccardi SM, Busco G, Cardone RA, Carrabino S, Weinman EJ, Reshkin SJ, Conese M, Casavola V: Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells. J Biol Chem 2005, 280:40925-40933
40. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR, Boucher RC: Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 2005, 16:2154-2167
41. Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-Corradini S, Mancino MG, Maggioni M, Attili AF, Podda M, Gaudio E: Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 2004, 41:905-912
42. Chen J, Robertson G, Field J, Liddle C, Farrell GC: Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Hepatology 1998, 28:624-630
43. Smith PM, Cowan A, Milgram SL, White BA: Tissue-specific regulation by estrogen of ezrin and ezrin/radixin/moesin-binding protein 50. Endocrine 2003, 22:119-126
44. Fanelli T, Cardone RA, Favia M, Guerra L, Zaccolo M, Monterisi S, De Santis T, Riccardi SM, Reshkin SJ, Casavola V: Beta-oestradiol rescues DeltaF508CFTR functional expression in human cystic fibrosis airway CFBE41o- cells through the up-regulation of NHERF1. Biol Cell 2008, 100:399-412
45. Francis H, Glaser S, Ueno Y, Lesage G, Marucci L, Benedetti A, Taffetani S, Marzioni M, Alvaro D, Venter J, Reichenbach R, Fava G, Phinizy JL, Alpini G: cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 2004, 41:528-537
46. Weinman E, Steplock D, Lamprecht G, Yun C, Shenolikar S: Regulation of the Na/H exchanger regulatory factor in OK cells. Mineral Electrolyte Metab 1999, 25:135-142
47. Voltz JW, Brush M, Sikes S, Steplock D, Weinman EJ, Shenolikar S: Phosphorylation of PDZI domain attenuates NHERF-1 binding to cellular targets. J Biol Chem 2007, 282:33879-33887
48. Pan Y, Weinman EJ, Dai J: NHERF1 (Na+/H+ exchanger regulatory factor 1) inhibits platelet-derived growth factor signaling in breast cancer cells. Breast Cancer Res 2008, 10:R5
49. Khundmiri SJ, Ahmad A, Bennett RE, Weinman EJ, Steplock D, Cole J, Baumann PD, Lewis J, Singh S, Clark BJ, Lederer ED: Novel regulatory function for NHERF-1 in Npt2a transcription. Am J Physiol 2008, 294:F840-F849